UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 15

 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDERSECTION 12(g) OF

THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER

SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

 

Commission File Number: 000-55523

 

Applied BioSciences Corp.

(Exact name of registrant as specified in its charter)

 

320 Park Ave.

New York, New York 10022

(212) 401-0097

(Address, include zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

Common Stock, $0.00001 par value per share  

(Title of each class of securities covered by this Form)

 

None

(Title of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

Rule 12g-4(a)(1)

Rule 12g-4(a)(2)

Rule 12h-3(b)(1)(i)

Rule 12h-3(b)(1)(ii)

Rule 15d-6

☒

¨

☒

¨

¨

Rule 15d-22(b)

¨

 

Approximate number of holders of record as of the certification or notice date: 62

 

Pursuant to the requirements of the Securities Exchange Act of 1934, Applied BioSciences Corp., has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

 

Applied BioSciences Corp.

 

Date: May 1, 2020

By

/s/ Chris Bridges

 

Name: Chris Bridges

 

Title: President (principal executive officer)

 

 

Grafico Azioni Applied Biosciences (CE) (USOTC:APPB)
Storico
Da Mar 2025 a Apr 2025 Clicca qui per i Grafici di Applied Biosciences (CE)
Grafico Azioni Applied Biosciences (CE) (USOTC:APPB)
Storico
Da Apr 2024 a Apr 2025 Clicca qui per i Grafici di Applied Biosciences (CE)